ASXL1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN)

被引：1

作者：

Elshoury, Amro ^{[1
]}

Yu, Han ^{[2
]}

Ji, Wenyan ^{[3
]}

Thompson, James E. ^{[4
]}

Griffiths, Elizabeth A. ^{[5
]}

Przespolewski, Amanda ^{[6
]}

Green, Steven Daniel

Sung, Pamela J. ^{[6
]}

Aqeel, Sheebaba ^{[4
]}

Awada, Hassan ^{[7
]}

Wang, Eunice S. ^{[1
,8
]}

Kouides, Peter A. ^{[9
]}

机构：

[1] Roswell Pk Comprehens Canc Ctr, Dept Med, Leukemia Serv, Buffalo, NY USA

[2] Roswell Pk Canc Inst, Dept Biostatist & Boinformat, Buffalo, NY USA

[3] Roswell Pk Comprehens, Dept Biostatist Bioinformat, Buffalo, NY USA

[4] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[5] Roswell Pk Comprehens Canc Ctr, Dept Internal Med, Div Hematol, Buffalo, NY USA

[6] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY USA

[7] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[8] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[9] Rochester Gen Hosp, Dept Hematol, Rochester, NY USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-146384

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3637

引用

页数：5

共 50 条

[1] ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms
Awada, Hassan
Bhatta, Manasa
Yu, Han
Ji, Wenyan
Hou, Surui
Cronin, Tara
Ba Aqeel, Sheeba
Roy, Arya Mariam
Faisal, Muhammad Salman
Kouides, Peter
Mascarenhas, John
Griffiths, Elizabeth A.
Elshoury, Amro
[J]. LEUKEMIA, 2024, 38 (01) : 210 - 214
[2] ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms
Hassan Awada
Manasa Bhatta
Han Yu
Wenyan Ji
Surui Hou
Tara Cronin
Sheeba Ba Aqeel
Arya Mariam Roy
Muhammad Salman Faisal
Peter Kouides
John Mascarenhas
Elizabeth A. Griffiths
Amro Elshoury
[J]. Leukemia, 2024, 38 : 210 - 214
[3] PLATELET COUNT AS A RISK FACTOR FOR HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Simonovic, E.
Macukanovic-Golubovic, L.
Colic, V.
[J]. HAEMATOLOGICA, 2016, 101 : 815 - 815
[4] RISK FACTORS FOR THROMBOTIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Simonovic, E.
Macukanovic-Golubovic, L.
Colic, V.
[J]. HAEMATOLOGICA, 2016, 101 : 814 - 814
[5] Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
Liisborg, Charlotte
Hasselbalch, Hans Carl
Sorensen, Torben Lykke
[J]. CANCERS, 2020, 12 (03)
[6] Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms
Lee, Myung-Won
Yeon, Sang-Hoon
Ryu, Hyewon
Song, Ik-Chan
Lee, Hyo-Jin
Yun, Hwan-Jung
Kim, Seon Young
Shin, Kyung Sook
Jo, Deog-Yeon
[J]. INTERNAL MEDICINE, 2022, 61 (23) : 3483 - 3490
[7] EARLY EXPERIENCE WITH THE ESTABLISHMENT OF A REGISTRY FOR PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS (MPN) IN HUNGARY
Dombi, P.
Egyed, M.
Illes, A.
Demeter, J.
Homor, L.
Bodnar, M.
Szerafin, L.
Simon, Z.
Udvardy, M.
[J]. HAEMATOLOGICA, 2015, 100 : 757 - 757
[8] RISK FACTORS FOR INCIDENCE OF HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Simonovic, E.
Macukanovic-Golubovic, L.
[J]. HAEMATOLOGICA, 2017, 102 : 819 - 820
[9] IMPORTANCE OF COAGULATION ASSESSMENT IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS PATIENTS
Kabat, M. Gasior
Pollmar, M. I. Rivas
Roman, M. T. Alvarez
Manzano, E. Monzon
Butta, P. Acuna
Salgado, E. G. Arias
Salces, M. Martin
Giulinai, M. Facal
Marugan, P. Gonzalez
De Bustamante, J. Martin
Serrano, L. Gomez
Barcenilla, S. Garcia
Castro, C. Ramos
Coll, N. Butta
Yuste, V. Jimenez
[J]. HAEMOPHILIA, 2023, 29 : 166 - 166
[10] Potential Role of JAK2V617F and ASXL1 Mutations as Biomarkers for Disease Outcomes Amongst Thai Patients with Philadelphia-Negative Myeloproliferative Neoplasms
Arnutti, P.
Apipongrat, D.
Numbenjapon, T.
Nimmanon, T.
Jindatanmanusan, P.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S26 - S26

← 1 2 3 4 5 →